Hikma Pharmaceuticals PLC
HIK
Ранг среди акций
#25470
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the... Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.
Цена акции
$22.61
Последняя синхронизация: 2026-10-19
Рыночная капитализация
$46.82M
Изменение (1 день)
0.48%
Изменение (1 год)
-52.26%
Страна
GB
Торговля Hikma Pharmaceuticals PLC (HIK)
Категория
Healthcare
Рыночная капитализация Hikma Pharmaceuticals PLC(HIK)
Рыночная капитализация: $46.82M
По состоянию на October 2026 рыночная капитализация Hikma Pharmaceuticals PLC составляет $46.82M. Согласно нашим данным, Hikma Pharmaceuticals PLC занимает 25470th место среди самых ценных компаний мира по рыночной капитализации. Рыночная капитализация — это общая рыночная стоимость всех находящихся в обращении акций публичной компании и обычно используется для оценки ее стоимости.
История рыночной капитализации Hikma Pharmaceuticals PLC с 2011 по 2026
HIK по сравнению с пятеркой самых популярных stocks
